iTeos Therapeutics Stock Price

0.20 (0.74%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 352,177
Bid Price 20.00
Ask Price 29.50
News -
Day High 27.405


52 Week Range


Day Low 26.34
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
iTeos Therapeutics Inc ITOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.20 0.74% 27.25 16:18:28
Open Price Low Price High Price Close Price Prev Close
26.71 26.34 27.405 27.25 27.05
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,922 352,177 $ 27.01 $ 9,514,001 - 16.21 - 52.43
Last Trade Time Type Quantity Stock Price Currency
16:11:23 2 $ 25.89 USD


Draw Mode:

iTeos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 968.48M 35.54M 23.36M $ 344.78M $ 224.69M 5.61 3.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.04M 0.30%

more financials information »

iTeos Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITOS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week25.3027.40523.8025.44279,4971.957.71%
1 Month22.0128.0521.5525.11366,7515.2423.81%
3 Months19.2528.0516.2120.80438,7858.0041.56%
6 Months36.3137.8816.2126.31434,847-9.06-24.95%
1 Year24.9252.4316.2130.91383,5752.339.35%
3 Years19.7052.4316.2129.56329,4017.5538.32%
5 Years19.7052.4316.2129.56329,4017.5538.32%

iTeos Therapeutics Description

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.

Your Recent History
iTeos Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now